Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.4.2.2 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.4.2.3 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.4.8 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.617.1 (Kappa)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.4.3 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.46.5 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XWNNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.1.10NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JN.8NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KG.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XDJNNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
HK.3.8NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
GK.1.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JN.5.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JN.1.36.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.86.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
LV.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
HK.23NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
GE.1.2.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JN.2.2.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JC.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KE.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FY.8.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
C.30NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.177.56NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JD.1.1.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.86NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.154NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.4.8NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
A.2.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.41NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.137NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.446NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.76 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.398NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.163NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
P.3 (Theta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.254NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.39.1.1 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.418NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.9.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.40NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.122NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XAJNNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.431NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.168NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
Q.6 (Alpha)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AZ.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.97NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.36.18NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used